Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Supports collaborative training programs between U.S. and LMIC institutions to enhance research capacity on infectious diseases with a focus on major endemic diseases in LMICs.
Funder: National Institutes of Health
Due Dates: August 6, 2024 (New/Renewal/Resubmission) | August 6, 2025 | August 6, 2026 (all by 5:00 PM local time) | Letter of Intent: 30 days before each due date
Funding Amounts: Up to $230,000/year (new awards) or $276,000/year (renewals) in direct costs; max project period 5 years.
Summary: Supports collaborative training programs between U.S. and LMIC institutions to build research capacity in infectious diseases of public health importance in LMICs.
Key Information: Clinical trial training is optional; HIV/AIDS-focused training is not supported under this program.
Description
This opportunity funds joint research training programs between U.S. and low- and middle-income country (LMIC) institutions to strengthen the capacity of LMIC institutions to conduct research on infectious diseases. The program is designed to address major endemic or emerging infectious diseases, neglected tropical diseases, infections that co-occur with HIV, and infections associated with non-communicable diseases in LMICs. Training may cover a broad range of scientific disciplines, including basic, epidemiological, clinical, behavioral, and social sciences, and can include clinical trial experience.
The program aims to develop a critical mass of LMIC scientists and health professionals with the expertise and leadership skills needed to conduct independent, sustainable, and internationally recognized infectious disease research relevant to their countries’ health priorities. Training programs must include didactic coursework, mentored research, and professional/career development components.
